MRNA Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $145.00M ; Cost of revenue $93.00M ; Research and development $651.00M ; Operating expenses (m) . 2026-03-31: Revenue $389.00M ; Cost of revenue $955.00M ; Research and development $649.00M ; Operating expenses (m) . 2025-12-31: Revenue $678.00M* ; Cost of revenue $452.00M* ; Research and development $775.00M* ; Operating expenses (m) . 2025-09-30: Revenue $1.02B ; Cost of revenue $207.00M ; Research and development $801.00M ; Operating expenses (m) . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
MRNA revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Grant $2.00M Product And Service Other $51.00M COVID19 $91.00M Collaboration Arrangement Including Arrangements With Affiliate $15.00M License And Royalty $3.00M Product Sales $94.00M RSV $3.00M Stand Ready Manufacturing $31.00M Revenue $145.00M Cost of revenue $93.00M Operating income -$815.00M Other income, net -$19.00M Research & development $651.00M Pre-tax income -$767.00M Income tax $15.00M Net income -$782.00M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Cost of revenue Research and development Operating expenses Income tax Net income 2026-06-30 $145.00M $93.00M $651.00M (m) $15.00M -$782.00M 2026-03-31 $389.00M $955.00M $649.00M (m) $9.00M -$1.34B 2025-12-31 $678.00M* $452.00M* $775.00M* (m) $27.00M* -$826.00M* 2025-09-30 $1.02B $207.00M $801.00M (m) $13.00M -$200.00M 2025-06-30 $142.00M $119.00M $700.00M (m) $7.00M -$825.00M 2025-03-31 $108.00M $90.00M $856.00M (m) $7.00M -$971.00M 2024-09-30 $1.86B $514.00M $1.14B (m) $8.00M $13.00M 2024-06-30 $241.00M $115.00M $1.22B (m) $0.00 -$1.28B 2024-03-31 $167.00M $96.00M $1.06B (m) $10.00M -$1.18B 2023-09-30 $1.83B $2.24B $1.16B (m) $1.67B -$3.63B 2023-06-30 $344.00M $731.00M $1.15B (m) -$369.00M -$1.38B 2023-03-31 $1.86B $792.00M $1.13B (m) -$384.00M $79.00M 2022-09-30 $3.36B $1.10B $820.00M (m) $174.00M $1.04B 2022-06-30 $4.75B $1.38B $710.00M (m) $277.00M $2.20B 2022-03-31 $6.07B $1.02B $554.00M (m) $572.00M $3.66B 2021-09-30 $4.97B $722.00M $521.00M (m) $219.00M $3.33B 2021-06-30 $4.35B $750.00M $421.00M (m) $283.00M $2.78B 2021-03-31 $1.94B $193.00M $401.00M (m) $39.00M $1.22B 2020-09-30 $157.00M $0.00 $344.00M $393.03M $1.00M -$233.00M 2020-06-30 $67.00M $0.00 $152.00M $188.48M $0.00 -$117.00M 2020-03-31 $8.00M $0.00 $115.00M $139.25M $0.00 -$124.00M 2019-12-31 $14.05M (m) (m) $144.61M (m) (m) 2019-09-30 $17.05M (m) $119.64M $147.81M -$178.00K -$123.22M 2019-06-30 $13.08M (m) $128.31M $156.79M -$324.00K -$134.94M 2019-03-31 $16.02M (m) $130.41M $157.67M -$24.00K -$132.58M 2018-12-31 $35.42M (m) (m) $188.45M (m) (m) 2018-09-30 $41.76M (m) $109.05M $127.58M $0.00 -$80.33M 2018-06-30 $28.85M (m) $104.48M $125.87M $158.00K -$90.60M 2018-03-31 $29.04M (m) $90.12M $106.44M $0.00 -$72.38M 2017-12-31 $91.90M (m) (m) $133.73M (m) (m) 2017-09-30 $42.47M (m) (m) $110.34M (m) (m) 2017-06-30 $41.12M (m) (m) $135.31M (m) (m) 2017-03-31 $30.33M (m) (m) $95.79M (m) (m)
Revenue and expense 6 month Period end Revenue Cost of revenue Research and development Operating expenses Income tax Net income 2026-06-30 $534.00M $1.05B $1.30B (m) $24.00M -$2.13B 2025-06-30 $250.00M $209.00M $1.56B (m) $14.00M -$1.80B 2024-06-30 $408.00M $211.00M $2.28B (m) $10.00M -$2.45B 2023-06-30 $2.21B $1.52B $2.28B (m) -$753.00M -$1.30B 2022-06-30 $10.81B $2.40B $1.26B (m) $849.00M $5.85B 2021-06-30 $6.29B $943.00M $822.00M (m) $322.00M $4.00B 2020-06-30 $75.00M $0.00 $267.00M $327.73M $0.00 -$241.00M 2019-06-30 $29.11M (m) $258.72M $314.46M -$348.00K -$267.52M 2018-06-30 $57.89M (m) $194.60M $232.31M $158.00K -$162.98M
Revenue and expense 9 month Period end Revenue Cost of revenue Research and development Operating expenses Income tax Net income 2025-09-30 $1.27B $416.00M $2.36B (m) $27.00M -$2.00B 2024-09-30 $2.27B $725.00M $3.42B (m) $18.00M -$2.44B 2023-09-30 $4.04B $3.76B $3.44B (m) $919.00M -$4.93B 2022-09-30 $14.18B $3.50B $2.08B (m) $1.02B $6.90B 2021-09-30 $11.26B $1.67B $1.34B (m) $541.00M $7.33B 2020-09-30 $232.00M $0.00 $611.00M $720.76M $1.00M -$474.00M 2019-09-30 $46.15M (m) $378.36M $462.27M -$526.00K -$390.73M 2018-09-30 $99.65M (m) $303.65M $359.88M $158.00K -$243.31M
Revenue and expense 12 month Period end Revenue Cost of revenue Research and development Operating expenses Income tax Net income 2025-12-31 $1.94B $868.00M $3.13B (m) $54.00M -$2.82B 2024-12-31 $3.24B $1.46B $4.54B (m) -$46.00M -$3.56B 2023-12-31 $6.85B $4.69B $4.84B (m) $772.00M -$4.71B 2022-12-31 $19.26B $5.42B $3.29B (m) $1.21B $8.36B 2021-12-31 $18.47B $2.62B $1.99B (m) $1.08B $12.20B 2020-12-31 $803.00M $8.00M $1.37B (m) $3.00M -$747.00M 2019-12-31 $60.00M $0.00 $496.00M $605.93M -$1.00M -$514.00M 2018-12-31 $135.07M $0.00 $454.08M $548.33M $326.00K -$384.73M 2017-12-31 $205.82M (m) $410.46M $475.18M -$80.00K -$255.92M 2016-12-31 $108.40M (m) $274.72M $332.17M $1.04M -$216.21M